![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
Direktor/Vorstandsmitglied bei
ANAVEX LIFE SCIENCES CORP.
Vermögen: 4 Mio $ am 31.08.2026
Profil
Christopher U.
Missling is currently Director at Anavex Life Sciences Corp.
since 2013.
Former positions include Chief Financial Officer at ImmunoGen, Inc., CFO & Senior Vice President-Strategic Operations at Curis, Inc., Head-Financial Planning at Aventis, Inc., and Head-Healthcare Investment Banking at Brimberg & Co. Education includes graduate and doctorate degrees from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.07.2026 | 1’510’165 ( 1.63% ) | 4 Mio $ | 31.08.2026 |
Aktive Positionen von Christopher Missling
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher Missling
| Unternehmen | Position | Ende |
|---|---|---|
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Finanzdirektor/CFO | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| CURIS, INC. | Finanzdirektor/CFO | - |
Ausbildung von Christopher Missling
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
